{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "DDR2",
                "DNA Alteration": "c.716T>G",
                "GeneMutation": "p.I638F Frameshift-GOF",
                "VariantAlleleFraction": "13.45%"
            },
            {
                "Gene": "EGFR",
                "DNA Alteration": "c.2235_2252del18",
                "GeneMutation": "p.G719A Spliceregionvariant-LOF",
                "VariantAlleleFraction": "16.87%"
            },
            {
                "Gene": "DPYD",
                "DNA Alteration": "c.2846A>T",
                "GeneMutation": "p.I543V Spliceregionvariant-LOF",
                "VariantAlleleFraction": "3.81%"
            },
            {
                "Gene": "ERBB2",
                "DNA Alteration": "c.2264_2278del",
                "GeneMutation": "p.S310F Frameshift-GOF",
                "VariantAlleleFraction": "1.41%"
            },
            {
                "Gene": "AKT1",
                "DNA Alteration": "c.49G>A",
                "GeneMutation": "p.E17K Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "5.4%"
            },
            {
                "Gene": "STAG2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R1012X Stopgain-LOF",
                "VariantAlleleFraction": "4.35%"
            }
        ],
        "Germline": [
            {
                "Gene": "FBXW7",
                "DNA Alteration": "c.1394G>A",
                "GeneMutation": "p.R465H Stopgain-LOF",
                "Condition": "catch"
            }
        ]
    }
}